NVP Associates, LLC reported 7 positions worth $328.19M for the quarter ended Jun 30, 2026, up 86.3% on the prior quarter. It opened 3 new positions, added to 0, trimmed 0 and exited 1. Its largest holding is MBX Biosciences, Inc. at 35.9% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| BLLN BillionToOne, Inc. | -513.3K | -100.0% | $40.52M | Exited |
| Holding | Shares Sold | Trade Value | Prior Weight |
|---|---|---|---|
| BLLN BillionToOne, Inc. | -513.3K | $40.52M | 23% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | MBX MBX Biosciences, Inc. | Healthcare | 2.14M | $117.93M | 35.93% | 0 | 0.0% | Unchanged | 4.46% |
| 2 | AVLN Avalyn Pharma Inc. | Healthcare | 2.27M | $74.68M | 22.75% | +2.27M | – | New | 5.12% |
| 3 | OMDA Omada Health, Inc. | Healthcare | 2.53M | $55.56M | 16.93% | 0 | 0.0% | Unchanged | 4.18% |
| 4 | ZBIO Zenas BioPharma, Inc. | Healthcare | 1.84M | $46.66M | 14.22% | 0 | 0.0% | Unchanged | 2.9% |
| 5 | SNOW Snowflake Inc. | Technology | 114.8K | $29.21M | 8.9% | +114.8K | – | New | 0.03% |
| 6 | GROV Grove Collaborative Holdings, Inc. | Consumer Staples | 3.23M | $4.03M | 1.23% | 0 | 0.0% | Unchanged | 7.95% |
| 7 | ONDS Ondas Inc. | Industrials | 15.6K | $128.56K | 0.039% | +15.6K | – | New | 0% |
Tip. Select a row to see that position’s full history at NVP Associates.
As of its Q2 2026 13F filing, NVP Associates, LLC’s five largest positions were MBX Biosciences, Inc. (MBX) at 35.9%, Avalyn Pharma Inc. (AVLN) at 22.8%, Omada Health, Inc. (OMDA) at 16.9%, Zenas BioPharma, Inc. (ZBIO) at 14.2%, Snowflake Inc. (SNOW) at 8.9% of the reported portfolio.
NVP Associates, LLC reported a 13F portfolio worth $328.19M across 7 positions for Q2 2026. That is up 86.3% from the previous quarter.
Its largest purchases by value were Avalyn Pharma Inc. ($74.68M), Snowflake Inc. ($29.21M), Ondas Inc. ($128.56K). It opened 3 new positions.
Its largest sales by value were BillionToOne, Inc. ($40.52M). It exited 1 positions entirely.
From the Form 13F-HR reports NVP Associates, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.